Cerus Stock Today

CERS Stock  USD 1.45  0.06  4.32%   

Performance

Very Weak

 
Weak
 
Strong

Odds Of Distress

Above Average

 
High
 
Low
Cerus is selling for under 1.45 as of the 15th of March 2025; that is 4.32% increase since the beginning of the trading day. The stock's lowest day price was 1.39. Cerus has over 56 % chance of experiencing financial distress in the next 2 years of operation and has generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 15th of December 2024 and ending today, the 15th of March 2025. Click here to learn more.
Business Domain
Health Care Equipment & Services
IPO Date
30th of January 1997
Category
Healthcare
Classification
Health Care
Cerus Corporation operates as a biomedical products company. The company was incorporated in 1991 and is headquartered in Concord, California. Cerus Corp operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 631 people. The company has 185.79 M outstanding shares of which 9.31 M shares are currently shorted by private and institutional investors with about 7.89 trading days to cover. More on Cerus

Moving together with Cerus Stock

  0.66COO Cooper Companies,PairCorr
  0.8RMD ResMed IncPairCorr

Moving against Cerus Stock

  0.44LUNG Pulmonx CorpPairCorr

Cerus Stock Highlights

CEO and President and DirectorWilliam Greenman
Business ConcentrationHealth Care Equipment & Supplies, Health Care Equipment & Services, Health Care, NASDAQ Composite, NASDAQ Health Care, NASDAQ Composite Total, Health Care, Health Care Equipment & Supplies, Medical Devices, Healthcare (View all Sectors)
Average Analyst Recommendation
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.940.8972
Sufficiently Up
Slightly volatile
Gross Profit Margin0.680.5521
Fairly Up
Very volatile
Total Current Liabilities39.3 M63.6 M
Way Down
Slightly volatile
Non Current Liabilities Total84.4 M80.4 M
Sufficiently Up
Slightly volatile
Total Assets117.6 M200.9 M
Way Down
Slightly volatile
Total Current Assets101.9 M152 M
Way Down
Slightly volatile
Debt Levels
Cerus can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Cerus' financial leverage. It provides some insight into what part of Cerus' total assets is financed by creditors.
Liquidity
Cerus currently holds 33.23 M in liabilities with Debt to Equity (D/E) ratio of 1.15, which is about average as compared to similar companies. Cerus has a current ratio of 2.04, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Cerus' use of debt, we should always consider it together with its cash and equity.

Total Cash From Operating Activities

11.93 Million
Cerus (CERS) is traded on NASDAQ Exchange in USA. It is located in 1220 Concord Avenue, Concord, CA, United States, 94520 and employs 614 people. Cerus is listed under Health Care Equipment & Supplies category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 258.25 M. Cerus conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. The entity has 185.79 M outstanding shares of which 9.31 M shares are currently shorted by private and institutional investors with about 7.89 trading days to cover. Cerus currently holds about 107.05 M in cash with 11.36 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.6.
Check Cerus Probability Of Bankruptcy
Ownership Allocation
Cerus holds a total of 185.79 Million outstanding shares. The majority of Cerus outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Cerus to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Cerus. Please pay attention to any change in the institutional holdings of Cerus as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Cerus Ownership Details

Cerus Stock Institutional Holders

InstituionRecorded OnShares
D. E. Shaw & Co Lp2024-12-31
3.4 M
Morgan Stanley - Brokerage Accounts2024-12-31
3.4 M
Millennium Management Llc2024-12-31
2.9 M
Ieq Capital, Llc2024-12-31
2.2 M
Ing Investment Management Llc2024-12-31
1.8 M
Citadel Advisors Llc2024-12-31
1.7 M
Charles Schwab Investment Management Inc2024-12-31
1.7 M
Northern Trust Corp2024-12-31
1.6 M
Goldman Sachs Group Inc2024-12-31
1.6 M
Ark Investment Management Llc2024-12-31
20.8 M
Baker Bros Advisors Lp2024-12-31
19.5 M
View Cerus Diagnostics

Cerus Historical Income Statement

At this time, Cerus' Minority Interest is comparatively stable compared to the past year. View More Fundamentals

Cerus Stock Against Markets

Cerus Corporate Management

Carol MooreSr. VP of Regulatory Affairs, Quality and ClinicalProfile
Matthew NotarianniDirector RelationsProfile
Richard BenjaminChief Medical OfficerProfile
Vivek JayaramanChief Commercial OfficerProfile

Additional Tools for Cerus Stock Analysis

When running Cerus' price analysis, check to measure Cerus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cerus is operating at the current time. Most of Cerus' value examination focuses on studying past and present price action to predict the probability of Cerus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cerus' price. Additionally, you may evaluate how the addition of Cerus to your portfolios can decrease your overall portfolio volatility.